LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 76 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,003,889 | -54.1% | 1,363,190 | -0.7% | 0.00% | 0.0% |
Q2 2023 | $4,366,833 | +33.0% | 1,373,218 | -1.3% | 0.00% | 0.0% |
Q1 2023 | $3,283,723 | -26.6% | 1,391,408 | +8.0% | 0.00% | -50.0% |
Q4 2022 | $4,471,189 | -42.4% | 1,288,527 | +21.6% | 0.00% | -33.3% |
Q3 2022 | $7,769,000 | +20.6% | 1,059,897 | +7.3% | 0.00% | +50.0% |
Q2 2022 | $6,442,000 | +28.1% | 988,109 | -0.7% | 0.00% | +100.0% |
Q1 2022 | $5,027,000 | -32.9% | 995,531 | +2.8% | 0.00% | -50.0% |
Q4 2021 | $7,493,000 | -48.1% | 968,065 | -0.7% | 0.00% | -50.0% |
Q3 2021 | $14,433,000 | -10.0% | 975,190 | -1.3% | 0.00% | -20.0% |
Q2 2021 | $16,044,000 | – | 987,928 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |